0000899243-18-006499.txt : 20180306
0000899243-18-006499.hdr.sgml : 20180306
20180306173127
ACCESSION NUMBER: 0000899243-18-006499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180305
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Frank Anders
CENTRAL INDEX KEY: 0001462948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05075
FILM NUMBER: 18671058
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERKINELMER INC
CENTRAL INDEX KEY: 0000031791
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042052042
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781 663 5776
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: EG&G INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC
DATE OF NAME CHANGE: 19670626
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-05
0
0000031791
PERKINELMER INC
PKI
0001462948
Wilson Frank Anders
940 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Please See Remarks
Common Stock
2018-03-05
4
M
0
31699
43.01
A
93624
D
Common Stock
2018-03-05
4
M
0
35114
46.255
A
128738
D
Common Stock
2018-03-05
4
M
0
28016
41.80
A
156754
D
Common Stock
2018-03-05
4
M
0
8827
52.65
A
165581
D
Common Stock
2018-03-05
4
S
0
55627
73.64
D
109654
D
Common Stock
2018-03-05
4
S
0
48029
74.28
D
61925
D
NQ Stock Option (right to buy)
43.01
2018-03-05
4
M
0
31699
0.00
D
2021-02-21
Common Stock
31699
0
D
NQ Stock Option (right to buy)
46.255
2018-03-05
4
M
0
35114
0.00
D
2022-02-03
Common Stock
35114
0
D
NQ Stock Option (right to buy)
41.80
2018-03-05
4
M
0
28016
0.00
D
2023-02-09
Common Stock
28016
14008
D
NQ Stock Option (right to buy)
52.65
2018-03-05
4
M
0
8827
0.00
D
2024-02-07
Common Stock
8827
17654
D
The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted.
This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted.
This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted.
This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
Senior Vice President and Chief Financial Officer
/s/ John L. Healy (POA on file) for Frank Anders Wilson
2018-03-06